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Abstrak 
 
Gagal ginjal kronik ditandai dengan menurunnya fungsi ginjal secara ireversibel yang telah berlansung lebih dari tiga 
bulan dengan nilai laju filtrasi glomerulus kurang dari 15 ml/menit/1,73m2. Hemodialisis merupakan salah satu terapi 
pengganti ginjal yang paling sering dilakukan, namun hemodialisis memiliki komplikasi terhadap perubahan tekanan 
darah dan kadar gula darah. Penelitian ini bertujuan untuk mengetahui perbandingan tekanan darah dan kadar gula 
darah pada pasien gagal ginjal kronik sebelum dan sesudah hemodialisis di unit hemodialisis RSUP dr. Mohammad 
Hoesin Palembang. Penelitian ini merupakan penelitian observasional analitik dengan desain longitudinal menggunakan 
pengukuran berulang. Subjek penelitian adalah 74 pasien gagal ginjal kronik yang memenuhi kriteria inklusi dan 
eksklusi. Data penelitian diperoleh melalui data primer (pengukuran dan wawancara) dan dianalisis menggunakan 
Paired T-Test dan Wilcoxon. Rata-rata tekanan darah sebelum hemodialisis adalah 150,14 ± 30,045 mmHg (sistolik) 
dan 83,99 ± 16,469 mmHg (diastolik) serta sesudah hemodialisis adalah 159,66 ± 33,570 mmHg (sistolik) dan 86,35 ± 
15,534 mmHg (diastolik). Rata-rata kadar gula darah sebelum hemodialisis adalah 161,61 ± 80,750 mg/dl serta sesudah 
hemodialisis adalah 131,51 ± 49,430 mg/dl. Hasil uji Paired T-Test menunjukkan perbandingan tekanan sistolik yang 
signifikan (p = 0,007), sedangkan hasil uji Wilcoxon menunjukkan perbandingan diastolik yang tidak signifikan (p = 
0,193) dan perbandingan kadar gula darah yang signifikan (p = 0,000). Terdapat perbandingan tekanan darah sistolik 
yang signifikan, tekanan darah diastolik yang tidak signifikan, dan kadar gula darah yang signifikan sebelum dan 
setelah hemodialisis pada pasien gagal ginjal kronik di RSUP dr. Mohammad Hoesin Palembang. 
 
Kata kunci:hemodialisis, tekanan darah, kadar gula darah 
 
Abstract 
 
Comparison of Blood Pressure and Blood Glucose Levelsin Chronic Kidney Failure Patients Before and After 
Hemodialysis Treatment in RSMH Palembang. Chronic kidney failure is irreversible decrease of kidney function 
with glomerular filtration rate < 15 ml/minute/1,73m2 for more than three months. Hemodialysis is the one of the most 
used kidney replacement therapy, but it has the complication for change of blood pressure and blood glucose levels. The 
goal of this research is to see the difference of blood pressure and blood glucose levels of chronic kidney failure patients 
before and after hemodialysis in hemodialysis unit of RSUP dr. Mohammad Hoesin Palembang. This is the 
observational research using longitudinal design with repeated measure. There were 74 patients who met the inclusion 
and exclusion criteria. Primary data was obtained by measuring and interview, and also analyzed using Paired T-Test 
and Wilcoxon. Results: The average of blood pressure before hemodialysis was 150,14 ± 30,045 mmHg (systolic) and 
83,99 ± 16,469 mmHg (diastolic) and blood pressure after hemodialysis was 159,66 ± 33,570 mmHg (systolic) and 
86,35 ± 15,534 mmHg (diastolic). The average of blood glucose level before hemodialysis was 161,61 ± 80,750 mg/dl 
and after hemodialysis was 131,51 ± 49,430 mg/dl. Paired T-Test showed significant systolic blood pressure 
comparison (p = 0,007). Wilcoxon showed not significant diastolic blood pressure comparison (p = 0,193) and 
significant blood glucose levels comparison (p = 0,000). There was significant systolic blood pressure comparison, 
there was not significant diastolic blood pressure comparison, and there was significant blood glucose levels 
comparison after hemodialysis treatment in chronic kidney failure patients in RSUP dr. Mohammad Hoesin Palembang. 
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1. Introduction 
 
Chronic kidney disease is a disease with 
various etiologies which ultimately causes a 
progressive decline in kidney function. The 
process of deteriorating kidney function will 
cause kidney failure. Chronic kidney failure is 
characterized by an irreversible decrease in 
kidney function that has lasted more than three 
months with a glomerular filtration rate of less 
than 15 ml/minute/1.73m2 that requires renal 
replacement therapy
1
. 
The population of the Indonesian 
population diagnosed with chronic kidney 
failure at the age of 15 years is 0.2% with the 
highest prevalence found in Central Sulawesi 
(0.5%), while the prevalence of the population 
of South Sumatra experiencing chronic renal 
failure is around 0.1%
2
.  As patients with 
chronic kidney failure increase, patients 
undergoing hemodialysis therapy are also 
increasing
3
. 
Hemodialysis is the most common kidney 
replacement therapy in many countries
4
.  
Hemodialysis is also routinely carried out in 
Indonesia
5
.The principle of hemodialysis is the 
process of diffusion of waste metabolic 
substances through the semipermeable 
membrane to the dialysate so that these 
substances can be removed from the body and 
can replace kidney function
6
.  
Hemodialysis can also cause many 
complications. Complications that can occur 
are intradialytic hypertension, which is an 
increase in blood pressure of more than 10 
mmHg after undergoing hemodialysis
7
. 
Intradialytic hypertension occurs in 54% of 
patients with chronic renal failure undergoing 
hemodialysis
3
. Factors that can cause 
intradialytic hypertension are volume 
overload, activation of the RAAS system, 
excessive ultrafiltration, sympathetic 
overactivity, erythropoietin induction therapy, 
elimination of antihypertensive drugs, and 
endothelial dysfunction. Intradialytic 
hypertension can increase patient mortality, 
especially cardiovascular-related
8
.  Another 
complication that can occur is intradialytic 
hypotension, which is a decrease in blood 
pressure of more than 20 mmHg after 
undergoing hemodialysis. Factors that play a 
role are lower dry weight, high intradialytic 
weight gain, use of dialysate acetate, excessive 
use of antihypertensive drugs, consumption of 
food during hemodialysis, high dialysate 
temperature, and the presence of autonomic 
neuropathy
6
.  
Hemodialysis can also cause a significant 
decrease in blood sugar levels, both in patients 
who have diabetes mellitus or not
9
. This can 
occur because the process of diffusion of the 
patient's blood sugar into the dialysate due to 
the use of glucose-free dialysate and the 
transfer of blood sugar to erythrocytes due to 
changes in acidity in the erythrocyte 
cytoplasm. Post-dialysis hypoglycemia can 
occur after the patient has undergone 
hemodialysis, with mild to severe symptoms 
such as decreased consciousness, coma, and 
death
10
. 
Based on research conducted by Ferdi in 
2016 at the RSUD dr. Ibnu Sutowo Baturaja, 
hemodialysis hasda significant influence on 
changes in blood pressure before and after 
undergoing hemodialysis, especially systolic 
blood pressure where blood pressure 
increases
11
. The research conducted by 
Elisabet in 2013 at H. Abdul Moeloek Bandar 
Lampung Hospital concluded that there were 
significant differences in blood sugar levels 
between before and after undergoing 
hemodialysis where there was a decrease in 
blood sugar levels after hemodialysis
12
. 
Patients with chronic kidney failure who 
undergo hemodialysis every year increase, so 
this should be the focus of attention because 
hemodialysis can cause various complications, 
especially changes in blood pressure and 
decreased blood sugar levels after 
hemodialysis.  Complications related to blood 
pressure and blood sugar levels can increase 
morbidity and mortality in patients with 
chronic renal failure undergoing hemodialysis, 
especially if these complications are not 
recognized by health workers who handle 
patients undergoing hemodialysis. Research 
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that directly examines the two variables both 
blood pressure and blood sugar levels in 
patients with chronic renal failure undergoing 
hemodialysis is also still a little done. Most 
studies only examine the effects of 
hemodialysis on blood pressure or blood sugar 
levels only. By examining both variables, 
researchers can analyze changes in blood 
pressure and blood sugar levels at the same 
time in patients who have diabetes mellitus or 
not after hemodialysis, considering patients 
with diabetes mellitus have complications 
related to blood pressure and blood sugar 
levels more often after undergoing 
hemodialysis. This is what prompted 
researchers to conduct research on the 
comparison of blood pressure and blood sugar 
levels in patients with chronic renal failure 
before and after hemodialysis in RSUP Moh. 
Hoesin Palembang on November 1, 2018 to 
November 16, 2018. 
 
2. Method 
 
This study is an observational analytic 
study using a longitudinal study design with 
repeated measurements. The research data was 
obtained through primary data with 
measurements of blood pressure and blood 
sugar levels and interviews. Sampling of 74 
patients was done by consecutive sampling 
method. The inclusion criteria in this study 
were patients who underwent hemodialysis on 
1 - 16 November 2018 who were willing to be 
examined and interviewed, while the exclusion 
criteria were blood sugar values unreadable on 
the glucometer. Then univariate analysis was 
performed to determine the frequency 
distribution and bivariate analysis with Paired 
T-Test or Wilcoxon to analyze the comparison 
of blood pressure and blood sugar levels. 
 
 
 
 
3. Result 
 
Table 1 shows the characteristics of 74 CRF 
patients based on age, sex, HD frequency, age 
of first HD, consumption of antihypertensive 
drugs, oral DM drugs, and insulin use, history 
of hypertension and diabetes mellitus, age of 
first suffering from hypertension and diabetes 
mellitus, and eating as long as HD. 
Men (74.3%) suffered more from CRF than 
women (25.7%). Age <45 years is the most 
age group (29.7%), while age 65 - 74 years is 
the least age group (13.5%). The age of the 
oldest patient is 73 years and the age of the 
youngest patient is 16 years. all patients 
undergo hemodialysis twice a week. Age <45 
years is the first age group undergoing the 
most hemodialysis (36.5%), while the age of 
65 - 74 years is the first age group to undergo 
the least hemodialysis (9.5%). 
Amlodipine is the most widely used 
antihypertensive drug before HD (43.5%). 
There were 3 patients taking oral DM drugs, 
namely glimepiride, and acarbose (glucobay). 
Novorapid is the most widely used insulin 
(66.6%). The group of patients who had a 
history of hypertension alone was the most 
group (50.0%), while the group of patients 
who did not have a history of hypertension or 
diabetes mellitus was the least group (16.2%). 
The age of 40 - 49 years is the first age group 
to suffer from hypertension (41.4%), while the 
age of <20 years is the first age group to suffer 
from hypertension at least (5.2%). The age of 
40 - 49 years is the first age group to suffer 
from diabetes mellitus (28.0%), while the age 
of 20-29 years is the first age group to suffer 
from diabetes mellitus at least (8.0%). Patients 
who ate during hemodialysis (77%) were more 
than those who did not eat during 
hemodialysis (23%).
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Table 1. Characteristics of CRF Patients (n = 74) 
 
Variable  Category N % 
Age 
<  45 years 21 28,4 
45 – 54 years 22 29,7 
55 – 64 years 21 28,4 
65 – 74 years 10 13,5 
Sex 
Man 55 74,3 
Woman 19 25,7 
HD Frequency 2 times 74 100 
First Age of 
HD 
<  45 years 27 36,5 
45 – 54 years 22 29.7 
55 – 64 years 18 24,3 
65 – 74 years 7 9,5 
Antihypertensi
ve, Oral 
Diabetic, and 
Insulin 
Medication 
Antihypertensive Drug 21 28,4 
Oral Diabetic Drug 2 2,8 
Insulin 2 2,8 
Antihypertensive + Oral 
Diabetic Drug 
1 1,4 
Oral Diabetes Drug + 
Insulin  
1 1,4 
Not All Three 47 63,5 
Antihypertensi
ve Medication 
Amlodipin 10 43,5 
Amlodipin + 
Kandesartan 
1 4,3 
Amlodipin + Klonidin  2 8,7 
Captopril 1 4,3 
Klonidin 3 13,0 
Kandesartan  2 8,7 
Nifedipin 1 4,3 
Valsartan 1 4,3 
Forgot Name of Drug 2 8,7 
Oral Diabetes 
Medication 
Glibenclamid 1 33,3 
Glimepiride 1 33,3 
Acarbose (Glucobay) 1 33,3 
Insulin 
Medication 
Novorapid 55 74,3 
Forgot Name of Insulin 19 25,7 
Hypertension 
and DM 
History 
Hipertensi Only 37 50,0 
DM Only 4 5,4 
Hipertensi and DM 21 28,4 
Not Both 12 16,2 
First Age of 
Hypertension 
<  20 years 3 5,2 
20 – 29 years 5 8,6 
30 - 39 years 8 13,8 
40 - 49 years 24 41,4 
50 - 59 years 13 22,4 
60 – 69 years 5 8,6 
First Age of 
DM 
20 – 29 years 2 8,0 
30 - 39 years 6 24,0 
40 - 49 years 7 28,0 
50 - 59 years 6 24,0 
60 – 69 years 4 16,0 
Eat during HD 
Yes 57 77 
No 17 23 
 
Table 2 shows the comparison of blood 
pressure before and after hemodialysis in all 
patients with CRF and based on a history of 
diabetes mellitus, consumption of 
antihypertensive drugs, and eating for the last 
1.5 hours of hemodialysis. 
Based on the Kolmogorov-Smirnov 
normality test, systolic blood pressure data in 
all CRF patients before and after hemodialysis 
were normally distributed, so the Paired T-
Test was used. The value of p_value = 0.007 
(α <0.05), which means that there is a 
significant increase in systolic blood pressure 
before and after hemodialysis. The lowest 
systolic blood pressure before hemodialysis is 
80 mmHg and after hemodialysis is 90 mmHg. 
The highest systolic pressure before 
hemodialysis is 250 mmHg and after 
hemodialysis is 280 mmHg. 
Based on the Kolmogorov-Smirnov 
normality test, diastolic blood pressure data in 
all CRF patients before and after hemodialysis 
were abnormally distributed so that the 
Wilcoxon test was performed. The value of 
p_value = 0.193 (α> 0.05), which means that 
there is no significant increase in diastolic 
blood pressure before and after hemodialysis. 
The lowest diastolic pressure before 
hemodialysis is 60 mmHg and after 
hemodialysis is 50 mmHg. The highest 
diastolic pressure before hemodialysis is 120 
mmHg and after hemodialysis is 110 mmHg. 
Based on the Shapiro-Wilk normality test, 
systolic blood pressure data in patients with 
CRF who had DM before and after 
hemodialysis were normally distributed so that 
the Paired T-Test was used. The value of 
p_value = 0.019 (α <0.05), which means that 
there is a significant increase in systolic blood 
pressure in patients with CRF who suffer from 
DM before and after hemodialysis. 
Based on the Shapiro-Wilk normality test, 
diastolic blood pressure data in CRF patients 
who have DM before and after hemodialysis 
are normally distributed so that Paired T-Test 
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is used. The value of p_value = 0.948 (α> 
0.05), which means that there is no significant 
decrease in diastolic blood pressure in patients 
with CRF who suffer from DM before and 
after hemodialysis. 
Based on the Shapiro-Wilk normality test, 
the systolic blood pressure data in CRF 
patients who did not experience DM before 
and after hemodialysis were normally 
distributed, so the Paired T-Test was used. The 
value of p_value = 0.081 (α> 0.05), which 
means that there is an insignificant increase in 
systolic blood pressure in patients with CRF 
who do not suffer from DM before and after 
hemodialysis. 
Based on the Shapiro-Wilk normality test, 
diastolic blood pressure data in CRF patients 
who did not experience DM before 
hemodialysis were normally distributed and 
after hemodialysis were abnormally 
distributed, the Wilcoxon test was used. The 
value of p_value = 0.140 (α> 0.05), which 
means there is an insignificant increase in 
diastolic blood pressure in patients with CRF 
who do not suffer from DM before and after 
hemodialysis. 
Based on the Shapiro-Wilk normality test, 
systolic blood pressure data in patients with 
CKD + Hypertension who consumed 
antihypertensive drugs before and after 
hemodialysis were normally distributed, so the 
Paired T-Test was used. The value of p_value 
= 0.869 (α> 0.05), which means there is an 
insignificant increase in systolic blood 
pressure in patients with CRD + hypertension 
who take antihypertensive drugs before and 
after hemodialysis. 
Based on the Shapiro-Wilk normality test, 
diastolic blood pressure data in CRF + 
Hypertension patients who consumed 
antihypertensive drugs before and after 
hemodialysis were normally distributed, so the 
Paired T-Test was used. The value of p_value 
= 0.958 (α> 0.05), which means that there is 
no significant decrease in diastolic blood 
pressure in patients with CRD + hypertension 
who take antihypertensive drugs before and 
after hemodialysis. 
Based on the Shapiro-Wilk normality test, 
systolic blood pressure data in patients who 
consumed food for the last 1.5 hours of 
hemodialysis before and after hemodialysis 
were normally distributed, so the Paired T-
Test was used. The value of p_value = 0.012 
(α <0.05), which means that there is a 
significant increase in systolic blood pressure 
in patients who consume food for the last 1.5 
hours of hemodialysis before and after 
hemodialysis. 
Based on the Shapiro-Wilk normality test, 
diastolic blood pressure data in patients who 
consumed food during the last 1.5 hours of 
hemodialysis before and after hemodialysis 
were normally distributed, so the Paired T-
Test was used.The value of p_value = 0.145 
(α> 0.05), which means that there is no 
significant decrease in diastolic blood pressure 
in patients who consume food for the last 1.5 
hours of hemodialysis before and after 
hemodialysis.
 
 
Tabel 2. Comparison of Blood Pressure Before and After Hemodialysis
Variable Blood Pressure Before HD After HD P value 
All Patients with CRF  
Systolic 150,14 ± 30,045 159,66 ± 33,570 0,007 
Diastolic 83,99 ± 16,469 86,35 ± 15,534 0,193 
Patients with CRF and DM 
Systolic 151,20 ± 24,035 163,40 ± 25,929 0,019 
Diastolic 88,00 ± 16,771 87,80 ± 15,349 0,948 
Patients with CRF and non-
DM 
Systolic 149,59 ± 32,911 157,76 ± 36,969 0,081 
Diastolic 81,94 ± 16,099 85,61 ± 15,733 0,140 
Antihypertensive Medication 
Before HD 
Systolic 154,35 ± 24,648 155,22 ± 27,447 0,869 
Diastolic 85,00 ± 18,278 84,78 ± 16,479 0,958 
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Eat for the Last 1.5 Hours of 
HD 
Systolic 164,00 ± 36,801 148,67 ± 34,614 0,012 
Diastolic 88,67 ± 17,674 80,67 ± 18,310 0,145 
Table 3 shows the comparison of blood 
sugar levels before and after hemodialysis in 
all patients with CRF and based on a history of 
diabetes mellitus, consumption of oral DM 
drugs, use of insulin and feeding during 
hemodialysis. 
Based on the Kolmogorov-Smirnov 
normality test, blood sugar levels in all CRF 
patients before hemodialysis were abnormally 
distributed and blood sugar levels after 
hemodialysis were normally distributed, so the 
Wilcoxon test was used. The value of p_value 
= 0,000 (α <0.05), which means that there is a 
significant decrease in blood sugar levels 
before and after hemodialysis. The lowest 
blood sugar level before hemodialysis is 69 
mg / dl and after hemodialysis is 65 mg / dl. 
The highest blood sugar level before 
hemodialysis is 427 mg / dl and after 
hemodialysis is 278 mg / dl. 
Based on the Shapiro-Wilk normality test, 
the blood sugar level data in CRF patients who 
had DM before and after hemodialysis were 
normally distributed, so the Paired T-Test was 
used. The value of p_value = 0.002 (α <0.05), 
which means that there is a significant 
decrease in blood sugar levels in CRF patients 
who suffer from DM before and after 
hemodialysis. 
Based on the Shapiro-Wilk normality test, 
blood sugar level data in patients with CRF 
who did not experience DM before and after 
hemodialysis were normally distributed, so the 
Paired T-Test was used. The value of p_value 
= 0.032 (α <0.05), which means that there is a 
significant decrease in blood sugar levels in 
CRF patients who do not suffer from DM 
before and after hemodialysis. 
Based on the Shapiro-Wilk normality test, 
blood sugar level data in patients with CRF + 
DM who took oral DM drugs before and after 
hemodialysis were normally distributed, so the 
Paired T-Test was used. The value of p_value 
= 0.092 (α> 0.05), which means that there is 
no significant decrease in blood sugar levels in 
patients with CRF + DM who take oral DM 
drugs before and after hemodialysis. 
Based on the Shapiro-Wilk normality test, 
blood sugar level data in patients with CRF + 
DM who use insulin before hemodialysis are 
abnormally distributed and after hemodialysis 
are normally distributed, so the Wilcoxon test 
is used. The value of p_value = 0.109 (α> 
0.05), which means there is a significant 
decrease in blood sugar levels in patients with 
CRF + DM who use insulin before and after 
hemodialysis. 
Based on the Kolmogorov-Smirnov 
normality test, blood sugar level data in 
patients with CRF consuming food during 
hemodialysis before and after hemodialysis are 
normally distributed, so the Paired T-Test was 
used. The value of p_value = 0.021 (α <0.05), 
which means that there is a significant 
decrease in blood sugar levels in CRF patients 
who consume food during hemodialysis before 
and after hemodialysis. 
Based on the Shapiro-Wilk normality test, 
the blood sugar level data in patients with CRF 
not consuming food during hemodialysis 
before hemodialysis were abnormally 
distributed and after hemodialysis were 
normally distributed, the Wilcoxon test was 
used. The value of p_value = 0,000 (α <0.05), 
which means that there is a significant 
decrease in blood sugar levels in CRF patients 
who do not eat food during hemodialysis 
before and after hemodialysis. 
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Tabel 3. Comparison of Blood Glucose Level Before and After Hemodialysis
 
4. Discussion 
 
Distribution of CRF Patients Undergoing 
Hemodialysis 
 In this study obtained from 74 patients 
with chronic kidney failure, men (74.3%) had 
more hemodialysis than women (25.7%). This 
is in accordance with the data from the Basic 
Health Research which reports that men 
undergo more hemodialysis than women with 
a ratio of 3: 2
13
. Most patients underwent 
hemodialysis in the age range of 45 - 54 years 
(29.7%). This is in accordance with the 
Indonesian Renal Registry report which states 
that the age group 45-64 is the most age group 
in patients undergoing hemodialysis
3
.  
 There were 78.4% of patients who had a 
history of hypertension and 33.8% of patients 
who had a history of diabetes mellitus. This is 
in line with Indonesian Renal Registry data 
which reports that hypertension (44%) is a 
concomitant disease that is more common in 
patients with chronic renal failure than 
diabetes mellitus (22%)
3
. 
 Amlodipine (13.6%) is the type of 
antihypertensive drug that is most consumed 
by patients with chronic renal failure and 
hypertension before undergoing hemodialysis. 
This is consistent with research conducted at 
Hakeem Abdul Hamid Hospital Centenary, 
India which states that Calcium Channel 
Blocker drugs are most often given because 
they do not experience excretion during 
dialysis and are associated with lower 
mortality and cardiovascular events
14
. 
 
 
 
Comparison of Blood Pressure Before and 
After Hemodialysis 
In this study it was found that there was a 
significant increase between systolic blood 
pressure before and after hemodialysis (p = 
0.007), whereas diastolic blood pressure did 
not increase significantly (p = 0, 193). This is 
in line with the research conducted by Ferdi 
in 2016 at Ibnu Sutowo Regional Hospital in 
Baturaja that there was an effect of 
hemodialysis on changes in systolic blood 
pressure (p = 0.001) and diastolic (p = 
0.686)
11
.The ultrafiltration process during 
hemodialysis causes a decrease in vascular 
volume which induces activation of the 
Angiotensin Renin Aldosterone System 
(RAAS) so that an increase in blood pressure 
increases after undergoing hemodialysis. 
The high number of patients who have a 
history of hypertension (78.4%) plays a role 
in causing an increase in blood pressure after 
undergoing hemodialysis because intradialytic 
hypertension is more common in patients who 
have a history of predialysis hypertension
15
. 
Use of bicarbonate dialysate in RSUP 
hemodialysis unit Dr. Moehammad Hoesin 
Palembang reduced the incidence of 
intradialisis hypotension. The study was 
conducted on 41 patients with stable chronic 
renal failure in dr. Soetomo Surabaya showed 
that the incidence of intradialytic hypotension 
was more common with the use of dialysate 
acetate than dialysate bicarbonate (56.1% vs 
2.4%)
16
. Diastolic blood pressure dysfunction 
that is often experienced by patients 
undergoing dialysis plays a role in increasing 
diastolic blood pressure which is not 
Variabel 
Blood Glucose Level 
P value 
Before Hemodialisis After Hemodialisis 
All Patients with CRF 161,61 ± 80,750 131,51 ± 49,430 0,000 
Patients with CRF and DM 212,80 ± 113,398 153,20 ± 53,927 0,002 
Patients with CRF and non-DM 135,49 ± 37,761 120,45 ± 43,496 0,032 
Anti Diabetic Oral Medication Before HD 250,00 ± 79,981 134,33 ± 40,821 0,092 
Insulin Medication Before HD 317,67 ± 242,776 153,00 ± 55,218 0,109 
Eat During HD 151,75 ± 62,879 135,65 ± 48,922 0,021 
Don’t Eat During HD 194,65 ± 120,027 117,65 ± 50,057 0,000 
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significant after undergoing hemodialysis. 
Diastolic blood pressure is often found to be 
higher in younger patients and decreases with 
age. This also causes an increased incidence 
of isolated hypertension in older patients 
undergoing hemodialysis
17
. 
An increase in post-dialysis systolic blood 
pressure is associated with an increased risk 
of cardiovascular mortality and other causes 
for the next four years. This can indicate the 
occurrence of excess fluid volume in patients 
subclinically, so it is recommended to 
evaluate the status of the fluid
18
.  
Systolic blood pressure in patients with 
CRF + DM experienced a significant increase 
after undergoing hemodialysis. Research 
conducted by Amalia in 2015 on 
hemodialysis using dialysate bicarbonate 
reported that a history of diabetic kidney 
disease is a risk factor for the occurrence of 
intradialytic hypertension. Endothelial 
dysfunction in DM patients causes a decrease 
in levels of Nitric Oxide (NO) which acts as a 
vasodilator
19
.  
The increase in systolic pressure 
experienced by patients taking 
antihypertensive drugs before undergoing 
hemodialysis (0.97 mmHg) is lower than the 
increase in systolic pressure on average for all 
patients undergoing hemodialysis (9.52 
mmHg). This is because antihypertensive 
therapy can reduce blood pressure in patients 
undergoing hemodialysis effectively
20
. 
Patients who consumed food during the 
last 1.5 hours during the hemodialysis session 
experienced a decrease in systolic and 
diastolic blood pressure, especially systolic 
pressure which decreased significantly (p = 
0.012). This is in line with the research 
conducted by Shavinglam et al., Which states 
that a significant decrease in blood pressure 
after undergoing hemodialysis lasts up to 90 
minutes because the body will reduce the 
return and accumulation of venous blood by 
reducing systemic vascular resistance.
21
.  
 
 
 
Comparison of Blood Sugar Levels Before 
and After Hemodialysis 
In this study it was found that there was a 
significant decrease in blood sugar levels 
before and after hemodialysis (p = 0,000). 
This research is in accordance with the 
research conducted by Elisabet at H. Abdul 
Moeloek Hospital in Bandar Lampung where 
there was a significant decrease in blood 
sugar levels of 42 ± 28.2 mg / dl after 
undergoing hemodialysis. This is because in 
the hemodialysis process there is a 
concentration gradient between blood glucose 
and dialysate so that the patient's glucose 
moves to dialysate
12
. Decreasing blood sugar 
levels after undergoing hemodialysis can 
cause hypoglycemia which also increases 
with increasing hemodialysis. Hypoglycemia 
can result in increased awareness, seizures, 
and even coma until death
10
.  
Blood sugar levels decreased significantly 
after hemodialysis in both patients with CRF 
who had DM (p = 0,000) or did not 
experience DM (p = 0.018), but the decrease 
in blood sugar levels experienced by patients 
with DM (59.60 mg / dl) was greater 
compared to patients who did not develop 
DM (15.04 mg / dl). These results are in 
accordance with the research conducted by 
Sakla and Sheriff at the Dialysis and 
Nephrology Unit, Zagazig, Egypt where the 
decrease in sugar levels in patients with DM 
was greater than those without DM (88.3 mg / 
dl compared to 39.8 mg / dl ) Patients who 
have diabetes mellitus have a higher 
concentration gradient between blood sugar 
and dialysate, in addition, a worse state of 
insulin resistance and glycemic control in 
patients with diabetes mellitus than those who 
do not have diabetes mellitus can cause this
13
.  
Patients who took oral DM drugs and used 
insulin before undergoing hemodialysis 
experienced a significant decrease in blood 
sugar (p = 0.092 and p = 0.109). This is in 
accordance with research conducted at the 
National Diabetes Center, Jordan in 2015 
which showed patients with good glycemic 
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control had insignificant decreases in blood 
sugar levels
18
.  
Decreased blood sugar levels in patients 
who did not eat during hemodialysis (77 mg / 
dl) were greater than those who ate (16.50 mg 
/ dl). These results are in line with research 
conducted at the Dialysis and Nephrology 
Unit, Egypt in 2015 where non-DM patients 
who consumed food had lower blood sugar 
levels (18.8 mg / dl) which were smaller than 
those who did not eat food (70.3 mg / dl)
13
. 
 
5. Conclusion 
 Characteristics of CRF patients undergoing 
hemodialysis at RSUP dr. Mohammad Hoesin 
Palembang is: 
a Patients who undergo hemodialysis are 
mostly in the age group 45 - 54 years 
(28.4%) 
b There were 55 men (74.3%) and 19 women 
(25.7%) who underwent hemodialysis 
c All patients undergo hemodialysis twice a 
week 
d Patients who underwent the first 
hemodialysis at most when in the age 
group <45 years (36.5%) 
e Amlodipine is the most widely used 
antihypertensive drug before undergoing 
hemodialysis (13.6%) 
f Glibenclamid, glimepiride, and acarbose 
(glucobay) are oral anti-DM drugs taken 
before undergoing hemodialysis. 
g Novorapid is the most widely used insulin 
before undergoing hemodialysis (66%) 
h There were 57 patients (77%) who 
consumed food during hemodialysis 
i People with chronic renal failure first had 
hypertension at most when they were 40 - 
49 years old (41.1%) 
j The first patients with chronic renal failure 
have diabetes mellitus when they are 40-49 
years old (28%) 
There is a significant comparison of 
systolic blood pressure before and after 
hemodialysis in all patients with CRF, CRF + 
DM, and eating for the last 1.5 hours of HD. 
Meanwhile, there was an insignificant 
comparison of systolic blood pressure before 
and after hemodialysis in patients with CRD 
+ non-DM and taking antihypertensive drugs 
before HD. 
There was no significant comparison of diastolic blood pressure before and after hemodialysis in all patients with CRF, CRF + DM, CRF + non-DM, taking antihypertensive drugs before HD, and eating for the last 1.5 hours of HD. 
There is a significant comparison of blood 
sugar levels before and after hemodialysis in 
all patients with CRF, CRD + DM, CRF + 
non-DM, tombs during HD, and not eating 
during HD. Meanwhile, there were 
insignificant comparisons of blood sugar 
levels before and after hemodialysis in 
patients taking oral DM drugs and insulin 
before HD. 
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